The project will explore the inequality in access to psychological care and differences in resources across all UK primary ...

Syros Pharmaceuticals announced that its phase 3 trial of tamibarotene in combination with azacitidine did not meet the primary endpoint for the treatment of myelodysplastic syndrome.

The National Academy for Primary Education (NAPE) and the European Union today released findings of a study titled ...

ED visits related to hallucinogen use are linked to a 21-fold increased risk of schizophrenia spectrum disorder, results of a ...

Canadian politicians are moving at an alarming speed to reverse its immigration policies, this time targeting students. The ...

FORT WORTH, Texas — The U.S. Army Corps of Engineers (USACE) Fort Worth District announced a new study Wednesday that's aimed ...